Abstract |
Hepatic encephalopathy (HE) is a frequent complication of cirrhosis which, in addition to producing a great social impact, deteriorates the quality of life of patients and is considered a sign of advanced liver disease and therefore a clinical indication for liver transplant evaluation. Patients who have had episodes of HE have a high risk of recurrence. Thus, after the HE episode resolves, it is recommended: control and prevention of precipitating factors (gastrointestinal bleeding, spontaneous bacterial peritonitis, use of diuretics with caution, avoid nervous system depressant medications), continued administration of non-absorbable disaccharides such as lactulose or lactitol, few or non-absorbable antibiotics such as rifaximin and assess the need for a liver transplant as the presence of a HE episode carries a poor prognosis in cirrhosis.
|
Authors | Rosa M Morillas, Marga Sala, Ramon Planas |
Journal | Medicina clinica
(Med Clin (Barc))
Vol. 142
Issue 11
Pg. 512-4
(Jun 06 2014)
ISSN: 1578-8989 [Electronic] Spain |
Vernacular Title | Profilaxis de la encefalopatía hepática. |
PMID | 24480288
(Publication Type: Journal Article, Review)
|
Copyright | Copyright © 2013 Elsevier España, S.L. All rights reserved. |
Chemical References |
- Anti-Bacterial Agents
- Central Nervous System Depressants
- Diuretics
- Rifamycins
- Sugar Alcohols
- Lactulose
- lactitol
- Rifaximin
|
Topics |
- Anti-Bacterial Agents
(administration & dosage, pharmacokinetics, therapeutic use)
- Central Nervous System Depressants
(adverse effects)
- Contraindications
- Diuretics
(adverse effects)
- Gastrointestinal Hemorrhage
(etiology)
- Hepatic Encephalopathy
(etiology, prevention & control)
- Humans
- Hyperammonemia
(etiology, prevention & control)
- Intestinal Absorption
- Lactulose
(administration & dosage, therapeutic use)
- Liver Cirrhosis
(complications, surgery)
- Liver Transplantation
- Meta-Analysis as Topic
- Peritonitis
(complications)
- Portasystemic Shunt, Surgical
(adverse effects)
- Postoperative Complications
(etiology, prevention & control)
- Recurrence
- Rifamycins
(administration & dosage, pharmacokinetics, therapeutic use)
- Rifaximin
- Risk Factors
- Sugar Alcohols
(administration & dosage, therapeutic use)
|